The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients.
about
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsTuberculosis: From an incurable scourge to a curable disease - journey over a millenniumPoint-of-care diagnosis of tuberculosis: past, present and futureThe diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarceCorrelation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden settingEDCTP regional networks of excellence: initial merits for planned clinical trials in Africa.Multicenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South AfricaXpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppressionDo adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluidRapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementationTesting Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries.The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates.Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?Exploring alternative biomaterials for diagnosis of pulmonary tuberculosis in HIV-negative patients by use of the GeneXpert MTB/RIF assay.Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments.Misdiagnosis of tuberculosis associated with some species of nontuberculous mycobacteria by GeneXpert MTB/RIF assay.Assessment of the quantitative ability of AdvanSure TB/NTM real-time PCR in respiratory specimens by comparison with phenotypic methodsImproved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong'oto infectious diseases hospital in Tanzania.Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern Africa.Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial
P2860
Q24200879-A0202E6E-C3BE-4588-9BE0-EF00D29BA06FQ26865560-AAD91BE7-BA85-4FB7-A4C8-FCE1AD820F6DQ27004667-ACA81320-B37C-4FA4-BED6-D63C7AC4E9ABQ28727351-3487175F-A6E1-475A-A515-07A638D526B2Q28729742-01165033-7813-45F6-9595-065C8395FE8AQ30393945-E68DE7AB-09A7-4776-84AB-65A2FF61C942Q33900136-D92FF368-A255-447A-A260-818FF846BA28Q33901601-12F194D0-61E3-45F9-B5B0-70E69BF56D16Q33924814-E7E2D50F-BDA7-426A-8C87-ED605DBCC5D4Q33924841-3F6A1B3C-9404-4714-A893-961F9A58E33AQ34976354-5CDDD626-AAED-4E69-AC99-EA3CCF44F45CQ35868619-3C685D44-5159-4CBB-9F37-E355CE1173AFQ36564933-37405E4A-DD21-471E-ACCF-C88086F7E3BEQ36715814-6BD53F84-D69B-4B99-A9BF-BF984221E788Q37336296-70DCD0CF-C7DE-4E03-9472-7C1AEB5D902EQ37732922-892D1730-207D-4757-A3C6-70F822A5C6ACQ38679711-CB62AC30-B6DB-4AC6-8EC2-493C87525DC8Q41860621-558E6499-F61B-44CD-8CB4-54736C95C8F3Q47155317-1EBBB27E-4B39-4095-A381-521EA0B74BDCQ54957532-358390A8-599B-4C33-A4AB-B4456D6278E4Q57276328-CFFE1A7E-6B21-4831-A5AC-86BC6A712CE5
P2860
The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The use of an automated quanti ...... atus of tuberculosis patients.
@ast
The use of an automated quanti ...... atus of tuberculosis patients.
@en
type
label
The use of an automated quanti ...... atus of tuberculosis patients.
@ast
The use of an automated quanti ...... atus of tuberculosis patients.
@en
prefLabel
The use of an automated quanti ...... atus of tuberculosis patients.
@ast
The use of an automated quanti ...... atus of tuberculosis patients.
@en
P2093
P2860
P356
P1476
The use of an automated quanti ...... atus of tuberculosis patients.
@en
P2093
Grant Theron
Hemant Kumar Mishra
Hridesh Kumar Mishra
Jonny Peter
Lancelot Pinto
Richard van Zyl-Smit
Surendra Kumar Sharma
P2860
P304
P356
10.1093/CID/CIR824
P407
P577
2011-12-01T00:00:00Z